ArticleHepatobiliary surgery and nutrition2026
Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients.
Soo Kyoung Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.